Literature DB >> 23925901

Molecular evolution of the VP7 gene of Japanese G2 rotaviruses before vaccine introduction.

L P Do1, T Nakagomi, Y H Doan, Y Kitahori, O Nakagomi.   

Abstract

Changes in the prevalence of G2 rotavirus after vaccine introduction are an important issue. However, such changes in a given country should be interpreted in the global context over time. We determined 35 Japanese G2 sequences and compared them with 508 globally collected G2 sequences. The D96N substitution, a substitution known to be associated with an abrupt increase in G2 strains and antigenic changes, emerged in those strains that formed a nascent lineage outside of the currently predominant lineage (sublineage IVa). Further studies are warranted to monitor the potential of their global spread, since they also appeared in Europe and Australia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925901     DOI: 10.1007/s00705-013-1804-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

Review 1.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

2.  Community based case-control study of rotavirus gastroenteritis among young children during 2008-2010 reveals vast genetic diversity and increased prevalence of G9 strains in Kolkata.

Authors:  Satarupa Mullick; Anupam Mukherjee; Santanu Ghosh; Gururaja P Pazhani; Dipika Sur; Byomkesh Manna; James P Nataro; Myron M Levine; Thandavarayan Ramamurthy; Mamta Chawla-Sarkar
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

3.  Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8].

Authors:  Esmeralda Vizzi; Oscar A Piñeros; M Daniela Oropeza; Laura Naranjo; José A Suárez; Rixio Fernández; José L Zambrano; Argelia Celis; Ferdinando Liprandi
Journal:  Virol J       Date:  2017-03-21       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.